Navigation Links
Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010
Date:9/21/2010

BOSTON, Sept. 21 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company will be holding its annual shareholder meeting on Tuesday, September 28, 2010 at 9:00am EDT. The meeting will be held at the Hilton of Boston/Dedham located at 25 Allied Drive, Dedham, MA 02026. The agenda for the 2010 shareholder's meeting include proposals to re-elect the current Board of Directors and approve the appointment of Fred Schiemann, CPA, as the Company's accountant.

Proxy statements describing the proposals on the agenda and proxy cards for use by shareholders that cannot attend the meeting in person were sent by mail, on or about September 14, 2010, to the Company's shareholders of record as of August 27, 2010 and to shareholders that hold shares registered with Pacific Stock Transfer Company.

The Company has posted its financial results for the first six months ended June 30, 2010 on Pink Sheets OTC Markets website (http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=sndy).

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Develops Relay Lense Adapter System For MammoView® Product Line
2. Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009
3. Solos Endoscopy, Inc. Appoints Experienced CFO To Financial Leadership Amidst Growth
4. Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R)
5. Solos Endoscopy, Inc. Set To Develop European Union Conforming CE Mark Technical File
6. Solos Endoscopy, Inc. Set To Develop New Polymer Dilator For MammoView(TM) System
7. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
8. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in February Issue of General Surgery News
9. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
10. Solos Endoscopy, Inc. Outlines Marketing Strategy for 2010 Campaign
11. Solos Endoscopy, Inc. Makes Significant Design Improvement To Its MammoView(TM) Ductoscope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):